Charles River Laboratories International (CRL) Revenue — Quarter Ended Jun 28, 2025
Revenue for the quarter increased compared to the prior quarter and also rose relative to the same quarter last year. The sequential improvement reversed a pattern of declines seen in recent quarters.
Key takeaway
Quarter ended Jun 28, 2025 · FY2025 Q2
Revenue for the quarter increased compared to the prior quarter and also rose relative to the same quarter last year. The sequential improvement reversed a pattern of declines seen in recent quarters.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1B
Revenue reported for this quarter.
Quarter-over-quarter
+4.9%
Change from the immediately preceding quarter.
Year-over-year
+0.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 28, 2024 | $1B | -1.6% |
| Dec 28, 2024 | $1B | -1.1% |
| Mar 29, 2025 | $984.2M | -2.7% |
| Jun 28, 2025 | $1B | +0.6% |
Revenue performance
The reported revenue moved higher on a sequential basis, marking a positive shift from the preceding quarter's decline. Year-over-year growth was modest but positive.
Quarterly comparison
Compared to the immediately preceding quarter, revenue increased. Versus the same quarter one year earlier, revenue also showed an increase.
What to watch
The filing context includes forward-looking statements regarding non-human primate supply chain risks and related legal matters.